Metimedi Pharmaceuticals SITEMAP

Contact

This is a contact us & notice from Metimedi Pharmaceuticals..

Notice

[OMT-110 Main Patent] Approving responses submitted to the Mexico Patent Office

Date : 2020.09.29
Writer : Admin
Views : 509

[OMT-110 Main Patent] 


Answers to 2nd office action submitted to the Mexico Institute of Industrial Property (IMPI) have been approved.

We pay the grant fee for the patent application and continue to make efforts to apply for the patent to Mexico.

맨 위로 이동합니다.